VYNE Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYNE and other ETFs, options, and stocks.About VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology.
CEODavid Domzalski
CEODavid Domzalski
Employees13
Employees13
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2011
Founded2011
Employees13
Employees13
VYNE Key Statistics
Market cap27.41M
Market cap27.41M
Price-Earnings ratio-1.43
Price-Earnings ratio-1.43
Dividend yield—
Dividend yield—
Average volume1.61M
Average volume1.61M
High today$1.73
High today$1.73
Low today$1.45
Low today$1.45
Open price$1.47
Open price$1.47
Volume1.06M
Volume1.06M
52 Week high$4.30
52 Week high$4.30
52 Week low$0.85
52 Week low$0.85
People also own
Based on the portfolios of people who own VYNE. This list is generated using Robinhood data, and it’s not a recommendation.